Clinical epidemiology of cardiac disease in renal transplant recipients.
Cardiovascular disease (CVD) is the major cause of death among renal transplant recipients (RTRs), accounting for 17-50% of deaths. Both cardiomyopathy (congestive heart failure [CHF] and left ventricular hypertrophy [LVH]) and ischemic heart disease (IHD) are important complications of renal transplantation, although the morbid impact of cardiomyopathy has been overlooked until recently. Echocardiographic disorders and clinical CHF occur far more frequently in RTRs than in the general population, suggesting that renal transplantation may be a state of accelerated heart failure. In contrast, the incidence of IHD in RTRs is similar to that in the Framingham cohort. Age, diabetes, and gender remain important markers of risk for both disorders. Smoking, hyperlipidemia, and hypertension appear to be the major reversible risk factors for IHD, while anemia and hypertension are major reversible risk factors for cardiomyopathy. Definitive evidence on optimal intervention is lacking. Clinical trials are needed to define optimum targets for treatment of these risk factors, especially hypertension and anemia.
Rigatto
Claudio
C
Department of Medicine, Section of Nephrology, St. Boniface General Hospital, University of Manitoba, Winnipeg, Canada. crigatto@sbgh.mb.ca
D003925:Diabetic Angiopathies / Q000453:epidemiology; D006084:Graft Rejection; D006331:Heart Diseases / Q000453:epidemiology*; D006333:Heart Failure / Q000453:epidemiology*; D006801:Humans; D006949:Hyperlipidemias / Q000453:epidemiology; D017379:Hypertrophy, Left Ventricular / Q000453:epidemiology*; D007674:Kidney Diseases / Q000453:epidemiology* / Q000601:surgery; D016030:Kidney Transplantation; D017202:Myocardial Ischemia / Q000453:epidemiology*; D012307:Risk Factors